SNSE
$1
Revenue | $2.85Mn |
Net Profits | $-7.41Mn |
Net Profit Margins | -260.51% |
Sensei Biotherapeutics Inc’s revenue jumped +Inf% since last year same period to $2.85Mn in the Q4 2023. On a quarterly growth basis, Sensei Biotherapeutics Inc has generated +Inf% jump in its revenue since last 3-months.
Sensei Biotherapeutics Inc’s net profit jumped 40.41% since last year same period to $-7.41Mn in the Q4 2023. On a quarterly growth basis, Sensei Biotherapeutics Inc has generated -4.07% fall in its net profits since last 3-months.
Sensei Biotherapeutics Inc’s net profit margin jumped NaN% since last year same period to -260.51% in the Q4 2023. On a quarterly growth basis, Sensei Biotherapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.27 |
EPS Estimate Current Year | -0.27 |
Sensei Biotherapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.27 - a 12.9% jump from last quarter’s estimates.
Sensei Biotherapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.27.
Earning Per Share (EPS) | -0.3 |
Return on Assets (ROA) | -0.24 |
Return on Equity (ROE) | -0.41 |
Sensei Biotherapeutics Inc’s earning per share (EPS) jumped 25% since last year same period to -0.3 in the Q4 2023. This indicates that the Sensei Biotherapeutics Inc has generated 25% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Sensei Biotherapeutics Inc’s return on assets (ROA) stands at -0.24.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Sensei Biotherapeutics Inc’s return on equity (ROE) stands at -0.41.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-03 | -0.33 | -0.31 | 6.06% |
2023-11-07 | -0.34 | -0.28 | 17.65% |
2024-02-29 | -0.31 | -0.3 | 3.23% |
2023-05-09 | -0.36 | -0.33 | 8.33% |